Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CHYM vs GSK✓SelectedUSD · GSKCHYM vs GSK performance historyLatest closeAs of-1.65%11/20
Stock and ETF performance explorer

CHYM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-18.2%
GSK return
+19.5%
Excess return
-37.8%
Maximum drawdown
-55.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.7%-0.1%-1.5%-1.6%
7D-9.6%-5.3%-4.2%-9.2%
30D-0.1%-3.7%+3.6%+0.1%
3M-5.0%-7.3%+2.2%-4.8%
6M+71.7%-4.2%+75.9%+71.9%
YTD+20.5%+0.9%+19.7%+19.5%
1Y+69.0%+7.3%+61.7%+66.5%
All-18.2%+19.5%-37.8%-19.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling